New BARDA Award: Colorado State University USA P
Post# of 36533
Product Name: SolaVAX Vaccine Development
View Announcement
Description:
SolaVAX™ is an inactivated virus vaccine platform that uses Riboflavin and UV light to selectively inactivate virus particles by directed damage to nucleic acids while preserving the integrity of the proteins and viral antigens.
Unique Impact:
This technology will generate a virus particle that contains all the potential antigenic targets for immune response for use in a vaccine without the capacity for replication post-infection.
Award Amount: $699,994.00
Cost Share: Yes